Biotech Values

[ghmm]

Thanks jq. I had thought PTC an interesting company then the DMD data appeared bad on the surface but going through a bit and seeing the dystrophin production made me re-reconsider. I also saw @AndyBiotech post something about one of PTC's drugs for an eye condition. I find RNA's valuation compelling but I am not as familiar with what they may have changed with their earlier compounds that is a big part of what is preventing me from a real life position (and I'd like it in the low 4's again ).

I actually own or am considering each stock I picked in the charity contest, not to say I'll end up owning all .

I was very surprised as well to see Clark pick rtrx I thought perhaps he liked one of their new programs. I like some of their programs (PKAN specifically though its early) and don't like others (their FSGS specifically).